Anika Therapeutics, Inc. (ANIK) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$112.8M

Net Income/Loss (FY2025)

-$10.9M

Total Assets (FY2025)

$190.3M

Total Equity (FY2025)

$143.5M

Cash Flows from Operating Activities (FY2025)

$11.2M

Source: Anika Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.